Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Change in Receivables (2016 - 2025)

Nutex Health's Change in Receivables history spans 15 years, with the latest figure at -$152.6 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 189.91% year-over-year to -$152.6 million; the TTM value through Dec 2025 reached $2.4 million, down 98.63%, while the annual FY2025 figure was $2.4 million, 98.63% down from the prior year.
  • Change in Receivables for Q4 2025 was -$152.6 million at Nutex Health, down from $152.8 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $169.7 million in Q4 2024 and bottomed at -$152.6 million in Q4 2025.
  • The 5-year median for Change in Receivables is $523976.5 (2022), against an average of $9.2 million.
  • The largest annual shift saw Change in Receivables surged 66332.86% in 2021 before it crashed 3244.46% in 2022.
  • A 5-year view of Change in Receivables shows it stood at -$30.2 million in 2021, then soared by 101.3% to $391953.0 in 2022, then soared by 579.82% to $2.7 million in 2023, then soared by 6268.85% to $169.7 million in 2024, then crashed by 189.91% to -$152.6 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Change in Receivables are -$152.6 million (Q4 2025), $152.8 million (Q3 2025), and $1.5 million (Q2 2025).